Market Place
Sourcing Support
All News #Library
Biotech
Exicure Reveals Fast Stem Cell Mobilization In Multiple Myeloma
05 Feb 2026 //
GLOBENEWSWIRE
Exicure Presents Burixafor Phase 2 Data at 2026 Tandem Meetings
21 Jan 2026 //
GLOBENEWSWIRE
Exicure Scores In Phase 2 Multiple Myeloma Program
09 Dec 2025 //
FIERCE BIOTECH
Exicure Unveils Positive Phase 2 Results For Burixafor
08 Dec 2025 //
GLOBENEWSWIRE
Burixafor Clinical Data Presented Orally at 2025 ASH Meet
03 Nov 2025 //
GLOBENEWSWIRE
Exicure Completes Last Patient Visit in Ph 2 GPC-100 MM Study
01 Aug 2025 //
BUSINESSWIRE
Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100
05 May 2025 //
BUSINESSWIRE
Exicure Partners with GPCR Therapeutics to Fuel Growth in Biotech
27 Dec 2024 //
BUSINESSWIRE
Exicure Enters $10M Financing & Reports Q3 2024 Results
14 Nov 2024 //
BUSINESSWIRE
Exicure, Inc. Receives Extension from Nasdaq Hearings Panel
18 Sep 2024 //
BUSINESSWIRE
Exicure, Inc. Reports Second Quarter 2024 Financial Results
13 Aug 2024 //
BUSINESSWIRE
Exicure`s CEO, CFO takes lead in search to bail out the biotech
30 May 2023 //
FIERCE BIOTECH
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.